Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05232188
Other study ID # NoyanOzluPCNL
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 1, 2020
Est. completion date January 1, 2023

Study information

Verified date December 2022
Source Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients will be randomly divided into two groups in order to evaluate the effect of the size of the access sheath (Amplatz) used in the Percutaneous Nephrolithotomy (PCNL) operation on kidney functions. After dilatation, 22French (Fr) Amplatz sheath will be placed in the first group, while 28Fr Amplatz sheath will be placed in the second group. The functional difference will be evaluated with preoperative and postoperative 3rd-month kidney scintigraphies (diethylenetriamine pentaacetic acid (DTPA) and technetium-99m dimercaptosuccinic acid (DMSA). In addition, Kidney Injury Molecule-1 (KIM-1) levels will be measured in the urine in order to be a predictor of functional loss in the early period.


Description:

PCNL has been applied for the last 30 years as the primary and most effective treatment method in patients with kidney stones of 2 cm or larger. The primary purpose of the operation is to ensure stone-freeness. Another aim is to keep the damage to kidney functions to a minimum, thanks to the endoscopic intervention. In this respect, PCNL is superior to open surgery and reduces morbidity. Renal access, dilatation, and fragmentation are the 3 important stages of the operation, and access and dilation significantly affect the final results of PCNL. The size of the access sheath used as a result of dilation determines the size of the tract where the endoscopic intervention will be made, and not only affects the postoperative results and success but also determines the factors that may affect the kidney functions such as bleeding and loss of parenchyma in the kidney. There are studies showing that less bleeding, shorter hospital stay, and better postoperative pain control are achieved with the reduction of access sheath size. In addition to conventional PCNL, methods such as mini PCNL, micro PCNL, ultra-mini PCNL, and tubeless PCNL, where the diameter of the access sheath and endoscope are gradually decreasing, both increase success and reduce morbidity. In our study, in order to examine the postoperative functional results of 22 Fr and 28 Fr accessory sheath size; - For the early period, the change in KIM-1 values, a validated biomarker in acute kidney injury, measured on the preoperative and postoperative day 1 will be proportioned between the groups, - For the late period, we aimed to compare the kidney functions in the mid-long term by proportioning the DMSA and DTPA values at the preoperative and postoperative 3rd month.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 88
Est. completion date January 1, 2023
Est. primary completion date December 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients with 2-3 cm kidney stones - Patients with an American Society of Anesthesiologists =2 score - BMI: Patients between 20 and 35 kg/m2 Exclusion Criteria: - Patients with preoperative renal failure - Patients with multiple access - Patients undergone renal transplantation - Patients with renal anomalies (horseshoe kidney, solitary kidney, double collecting system, etc.) - Patients with history of open kidney stones surgery and/or PCNL history - Patients who cannot be stone-free in the postoperative period (fragments >4 mm in imaging) and require additional treatment intervention - Patients with bleeding disorders - Pregnant patients - Patients with complete staghorn stones - Patients with bilateral obstructive stones - Patients with active infection

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Percutaneous nephrolithotomy
percutaneous nephrolithotomy surgery, 22F amplatz sheath is used in one group, while 28F amplatz sheath is used in the other group.

Locations

Country Name City State
Turkey Bakirköy Dr. Sadi Konuk Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Differential function changes Differential function changes in the operated kidney in postoperative DMSA and DTPA 3 months
Primary Newly developed scar Presence of newly developed scar in DMSA 3 months
Primary KIM-1 Change in urinary KIM-1 levels 24 hours
Secondary Creatinine Postoperative changes in creatinine 24 hours
Secondary Glomerular filtration rate Postoperative changes in glomerular filtration rate 24 hours
Secondary Stone-free rate Postoperative stone-free rates 24 hours
Secondary Complications Complications according to Clavian grading 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT02993029 - 99Tc-MDP Treatment for Knee Osteoarthritis N/A
Enrolling by invitation NCT05411393 - Synergizing Home Health Rehabilitation Therapy N/A
Recruiting NCT05621356 - Monitoring Allergen Immunotherapy in Allergic Rhinitis
Not yet recruiting NCT05593380 - The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH N/A
Recruiting NCT05964725 - The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus N/A
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Recruiting NCT04013646 - Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients Phase 1/Phase 2
Not yet recruiting NCT03477240 - Feasibility Study Of A Telephonic Questionnaire For Follow-Up Of Locally Advanced Cervical Cancer Patients
Recruiting NCT06035783 - Calcium Reduction by Orbital Atherectomy in Western Europe
Recruiting NCT05413707 - Weber B Ankle Fractures With Associated Posterior Malleolus Fracture N/A
Completed NCT01364649 - Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction Phase 3
Completed NCT04682951 - Good Prognosis Factors After Decompressive Craniectomy : a Ten-year Retrospective Study
Recruiting NCT05616559 - Precision Medicine in the Depression Treatment
Recruiting NCT06441110 - Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer Phase 3
Recruiting NCT03223142 - Standardization of Multi-modal Tumor Ablation Therapy System N/A
Completed NCT05594160 - Agentic Self-view as Common Factor in Psychotherapy - Self-efficacy in the Treatment of Inpatients Over the Course of Time
Recruiting NCT05851989 - Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
Not yet recruiting NCT05885919 - Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Phase 3
Enrolling by invitation NCT06367829 - Lubinus SPII Hip Stem Target Trial Emulation (LARGE)
Active, not recruiting NCT01235104 - Impact of Total Nephrectomy on Patients With Kidney Stone N/A